See also this year's filing and all EDGAR filings for this company.
PDF Report 0001597553_2021_Sage_Therapeutics_Inc.pdf
Logs
Graph
Absolute values for 0001597553, Sage Therapeutics Inc.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 2,122,370,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 6,755,000 |
| 3 | remainder_Assets | 30,121,000 |
| 4 | LiabilitiesCurrent | 67,204,000 |
| 5 | LiabilitiesNoncurrent | 19,708,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 196,952,000 |
| 9 | ResearchAndDevelopmentExpense | 292,714,000 |
| 10 | remainder_Expenses | 28,308,000 |
| 11 | remainder_Revenues | 1,114,200,000 |
| 12 | remainder_NetIncome | 9,847,000 |
| 13 | remainder_ComprehensiveNetIncome | -880,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 2,159,246,000 |
| 1 | Liabilities | 86,912,000 |
| 2 | Expenses | 517,974,000 |
| 3 | Revenues | 1,114,200,000 |
| 4 | StockholdersEquity | 2,072,334,000 |
| 5 | NetIncome | 606,073,000 |
| 6 | ComprehensiveNetIncome | 605,633,000 |
| 7 | BaseVar | 1,944,529,500 |
| 8 | EconomicCapitalRatio | 3.71 |
Edgar->Model Mapping
Feature Distribution
Change over Time
